These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. D-penicillamine in the therapy of Indian childhood cirrhosis. Bhave S; Pandit A Indian J Pediatr; 1987; 54(4):587-90. PubMed ID: 3308697 [No Abstract] [Full Text] [Related]
6. Indian childhood cirrhosis in an American child. Adamson M; Reiner B; Olson JL; Goodman Z; Plotnick L; Bernardini I; Gahl WA Gastroenterology; 1992 May; 102(5):1771-7. PubMed ID: 1568588 [TBL] [Abstract][Full Text] [Related]
7. D-penicillamine in the treatment of Indian childhood cirrhosis--a preliminary report. Tomar BS; Saxena S; Prakash P; Tomar S; Verma C Indian J Pediatr; 1983; 50(407):613-8. PubMed ID: 6680110 [No Abstract] [Full Text] [Related]
8. Clinical trials of penicillamine in Indian childhood cirrhosis. Tanner MS; Bhave SA; Pradhan AM; Pandit AN Arch Dis Child; 1987 Nov; 62(11):1118-24. PubMed ID: 3318711 [TBL] [Abstract][Full Text] [Related]
9. Long term survival in Indian childhood cirrhosis treated with D-penicillamine. Bavdekar AR; Bhave SA; Pradhan AM; Pandit AN; Tanner MS Arch Dis Child; 1996 Jan; 74(1):32-5. PubMed ID: 8660042 [TBL] [Abstract][Full Text] [Related]
10. Reversal of Indian childhood cirrhosis by D-penicillamine therapy. Pradhan AM; Bhave SA; Joshi VV; Bavdekar AR; Pandit AN; Tanner MS J Pediatr Gastroenterol Nutr; 1995 Jan; 20(1):28-35. PubMed ID: 7884615 [TBL] [Abstract][Full Text] [Related]
12. Role of copper in Indian childhood cirrhosis. Tanner MS Am J Clin Nutr; 1998 May; 67(5 Suppl):1074S-1081S. PubMed ID: 9587155 [TBL] [Abstract][Full Text] [Related]
13. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Falkmer S; Samuelson G; Sjölin S Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388 [No Abstract] [Full Text] [Related]
14. D-penicillamine. Singh S; Kohli V Indian Pediatr; 1991 Jul; 28(7):779-85. PubMed ID: 1800352 [No Abstract] [Full Text] [Related]
15. Combination therapy with andrographolide and d-penicillamine enhanced therapeutic advantage over monotherapy with d-penicillamine in attenuating fibrogenic response and cell death in the periportal zone of liver in rats during copper toxicosis. Roy DN; Sen G; Chowdhury KD; Biswas T Toxicol Appl Pharmacol; 2011 Jan; 250(1):54-68. PubMed ID: 20946909 [TBL] [Abstract][Full Text] [Related]
17. [Myasthenia syndrome in D-penicillamine therapy in primary biliary cirrhosis]. Weinzierl M; Kruis W; Eisenburg J Internist (Berl); 1981 Feb; 22(2):93-5. PubMed ID: 7012074 [No Abstract] [Full Text] [Related]
18. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis]. Gichev IuP; Bakulina LF Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399 [No Abstract] [Full Text] [Related]
19. [Results of controlled therapeutic trials of D-penicillamine in chronic hepatitis]. Bielawski W; Kaszewska-Jablońska I; Górski M Pol Arch Med Wewn; 1976; 55(3):211-21. PubMed ID: 1257111 [No Abstract] [Full Text] [Related]
20. D-penicillamine in patients with postnecrotic liver cirrhosis. Tarantino G; Guardascione AM; Rossi A; Carandente B; Ciccarelli AF; De Michele NG; De Rosa G; Pannain M Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):3-10. PubMed ID: 3274901 [No Abstract] [Full Text] [Related] [Next] [New Search]